• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知症状在各种癌症中的表现。

Cognitive Symptoms Across Diverse Cancers.

机构信息

Lawrence Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.

Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

出版信息

JAMA Netw Open. 2024 Aug 1;7(8):e2430833. doi: 10.1001/jamanetworkopen.2024.30833.

DOI:10.1001/jamanetworkopen.2024.30833
PMID:39196555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11358862/
Abstract

IMPORTANCE

Psychosocial health services for adults with cancer should include support for cognitive symptoms and symptom clusters.

OBJECTIVE

To characterize the frequency and severity of cognitive symptoms and to identify demographic and clinical risk factors associated with moderate to severe cognitive symptoms among outpatient adults with cancer seeking psychosocial support.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed data from routine patient-reported symptom screening during clinic appointments at the Princess Margaret Cancer Centre in Toronto, Canada, between January 1, 2013, and December 31, 2019. Participants were outpatient adults (aged ≥18 years) with diverse cancer diagnoses who endorsed interest in receiving psychosocial support from a health care team member. Data analysis was performed from April 2020 to June 2024.

MAIN OUTCOMES AND MEASURES

The presence and severity of cognitive symptoms as self-rated by participants were characterized across 12 cancer types: brain or central nervous system (CNS), breast, gastrointestinal, head and neck, gynecological, thyroid, lung and bronchus, sarcoma, genitourinary, melanoma, hematological, and all other cancers. Multivariable logistic regression was used to explore the associations between demographic, clinical, and symptom factors and moderate to severe cognitive symptoms.

RESULTS

Across the sample of 5078 respondents (2820 females [55.5%]; mean [SD] age at time of survey, 56.0 [14.1] years) requesting psychosocial support, 3480 (68.5%) reported cognitive symptoms of any severity, ranging from 59.5% in sarcoma to 86.5% in brain or CNS cancer. Moderate to severe cognitive symptoms were reported by 1544 patients (30.4%), with the proportions being 51.3% for patients with brain or CNS, 37.0% for breast, 36.2% for thyroid, 30.9% for melanoma, 29.6% for head and neck, 28.3% for gastrointestinal, 28.2% for hematological, 28.1% for gynecological, 24.9% for lung and bronchus, 24.9% for sarcoma, 21.0% for genitourinary, and 26.8% for all other cancers. Across the entire sample, moderate to severe cognitive symptoms were associated with recurrence or progression involving the CNS (odds ratio [OR], 2.62; 95% CI, 1.80-3.81), depression (OR, 1.92; 95% CI, 1.59-2.31), tiredness (OR, 1.82; 95% CI, 1.52-2.19), drowsiness (OR, 1.64; 95% CI, 1.39-1.93), anxiety (OR, 1.57; 95% CI, 1.30-1.89), shortness of breath (OR, 1.38; 95% CI, 1.16-1.61), female sex (OR, 1.33; 95% CI, 1.14-1.56), first-line chemotherapy received (OR, 1.22; 95% CI, 1.05-1.41), and metastatic disease at diagnosis (OR, 0.74; 95% CI, 0.61-0.89). Within individual cancer types, tiredness and depression were consistently associated with moderate to severe cognitive symptoms.

CONCLUSIONS AND RELEVANCE

This cross-sectional study found that cognitive symptoms were frequently reported by patients across a wide range of cancer types; higher severity of cognitive symptoms was consistently associated with higher symptom burden. The findings could be used to inform decision-making regarding access to cognitive screening, assessment, and supportive care in outpatient oncology clinics.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394d/11358862/e3053a59a3a2/jamanetwopen-e2430833-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394d/11358862/e3053a59a3a2/jamanetwopen-e2430833-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394d/11358862/e3053a59a3a2/jamanetwopen-e2430833-g001.jpg
摘要

重要性

成人癌症患者的心理社会健康服务应包括对认知症状和症状群的支持。

目的

描述认知症状的频率和严重程度,并确定与寻求心理社会支持的门诊癌症成人中中度至重度认知症状相关的人口统计学和临床风险因素。

设计、地点和参与者:这项横断面研究分析了 2013 年 1 月 1 日至 2019 年 12 月 31 日期间在加拿大多伦多玛格丽特公主癌症中心就诊时通过常规患者报告症状筛查获得的数据。参与者为年龄≥18 岁、患有各种癌症诊断且表示有兴趣接受医疗团队成员提供心理社会支持的门诊成年人。数据分析于 2020 年 4 月至 2024 年 6 月进行。

主要结果和措施

通过参与者自我报告的认知症状的存在和严重程度来描述 12 种癌症类型:脑或中枢神经系统(CNS)、乳房、胃肠道、头颈部、妇科、甲状腺、肺和支气管、肉瘤、泌尿生殖、黑色素瘤、血液学和所有其他癌症。多变量逻辑回归用于探讨人口统计学、临床和症状因素与中度至重度认知症状之间的关联。

结果

在请求心理社会支持的 5078 名受访者(2820 名女性[55.5%];调查时的平均[SD]年龄,56.0[14.1]岁)的样本中,3480 名(68.5%)报告了任何严重程度的认知症状,范围从肉瘤的 59.5%到脑或 CNS 癌症的 86.5%。1544 名患者(30.4%)报告了中度至重度认知症状,其中脑或 CNS 的比例为 51.3%、乳房为 37.0%、甲状腺为 36.2%、黑色素瘤为 30.9%、头颈部为 29.6%、胃肠道为 28.3%、血液学为 28.2%、妇科为 28.1%、肺和支气管为 24.9%、肉瘤为 24.9%、泌尿生殖为 21.0%、其他所有癌症为 26.8%。在整个样本中,中度至重度认知症状与涉及中枢神经系统的复发或进展(比值比[OR],2.62;95%置信区间[CI],1.80-3.81)、抑郁(OR,1.92;95%CI,1.59-2.31)、疲劳(OR,1.82;95%CI,1.52-2.19)、困倦(OR,1.64;95%CI,1.39-1.93)、焦虑(OR,1.57;95%CI,1.30-1.89)、呼吸急促(OR,1.38;95%CI,1.16-1.61)、女性(OR,1.33;95%CI,1.14-1.56)、接受一线化疗(OR,1.22;95%CI,1.05-1.41)和诊断时的转移性疾病(OR,0.74;95%CI,0.61-0.89)相关。在个别癌症类型中,疲劳和抑郁与中度至重度认知症状始终相关。

结论和相关性

这项横断面研究发现,认知症状在广泛的癌症类型中经常被患者报告;认知症状的严重程度越高,与更高的症状负担一致。研究结果可用于为门诊肿瘤诊所的认知筛查、评估和支持性护理的决策提供信息。

相似文献

1
Cognitive Symptoms Across Diverse Cancers.认知症状在各种癌症中的表现。
JAMA Netw Open. 2024 Aug 1;7(8):e2430833. doi: 10.1001/jamanetworkopen.2024.30833.
2
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.在癌症门诊患者中使用通用不良事件术语标准和其他患者报告症状结局工具进行常规评估的可接受性:玛格丽特公主癌症中心的经验。
Oncologist. 2019 Nov;24(11):e1219-e1227. doi: 10.1634/theoncologist.2018-0830. Epub 2019 Aug 13.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Age-related differences in symptom distress among patients with cancer.癌症患者症状困扰的年龄相关差异。
J Geriatr Oncol. 2023 Nov;14(8):101601. doi: 10.1016/j.jgo.2023.101601. Epub 2023 Aug 18.
5
Telephone interventions for symptom management in adults with cancer.针对成年癌症患者症状管理的电话干预措施。
Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2.
6
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.风险因素与口咽癌长期幸存者患者报告的嗓音和言语症状的关联。
JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):615-623. doi: 10.1001/jamaoto.2021.0698.
7
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.全省范围内的 IV 期非小细胞肺癌患者报告结局分析。
Oncologist. 2021 Oct;26(10):e1800-e1811. doi: 10.1002/onco.13890. Epub 2021 Jul 17.
8
Association of Self-reported Presenting Symptoms With Timeliness of Help-Seeking Among Adolescents and Young Adults With Cancer in the BRIGHTLIGHT Study.BRIGHTLIGHT 研究中报告的症状与青少年和年轻癌症患者寻求帮助及时性之间的关联。
JAMA Netw Open. 2020 Sep 1;3(9):e2015437. doi: 10.1001/jamanetworkopen.2020.15437.
9
Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.接受姑息化疗的食管癌和胃癌患者的症状演变:一项基于人群的研究。
Ann Surg Oncol. 2021 Jan;28(1):79-87. doi: 10.1245/s10434-020-09289-6. Epub 2020 Nov 2.
10
Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer: A Prospective Longitudinal Multinational Study (EPCCS).轻度至中度认知障碍不会影响癌症患者自我报告重要症状的能力:一项前瞻性纵向多国研究(EPCCS)。
J Pain Symptom Manage. 2020 Aug;60(2):346-354.e2. doi: 10.1016/j.jpainsymman.2020.03.007. Epub 2020 Mar 14.

引用本文的文献

1
Modified Target Delineation and Moderately Hypofractionated Radiotherapy for High-Grade Glioma: A Randomized Clinical Trial.改良靶区勾画与中等分割放疗用于高级别胶质瘤:一项随机临床试验
JAMA Netw Open. 2025 Jul 1;8(7):e2523053. doi: 10.1001/jamanetworkopen.2025.23053.
2
Nutritional management adherence via an ePRO platform in patients with cancer: a machine learning model study.通过电子患者报告结果(ePRO)平台对癌症患者进行营养管理依从性:一项机器学习模型研究。
EClinicalMedicine. 2025 Jul 2;85:103330. doi: 10.1016/j.eclinm.2025.103330. eCollection 2025 Jul.
3
Symptom distress among Chinese children with cancer: what factors influence parent-child concordance?

本文引用的文献

1
Survivorship concerns among individuals diagnosed with metastatic cancer: Findings from the Cancer Experience Registry.转移性癌症确诊患者的生存问题:癌症经历登记处的调查结果
J Cancer Surviv. 2024 Apr 9. doi: 10.1007/s11764-024-01573-8.
2
The Multifactorial Model of Cancer-Related Cognitive Impairment.癌症相关认知障碍的多因素模型。
Oncol Nurs Forum. 2023 Feb 17;50(2):135-147. doi: 10.1188/23.ONF.135-147.
3
Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors' experiences of ongoing physical effects, novel treatments, uncertainty, and coping.
中国癌症患儿的症状困扰:哪些因素影响亲子一致性?
Eur J Pediatr. 2025 Jun 17;184(7):425. doi: 10.1007/s00431-025-06265-8.
4
Donepezil for cancer-related cognitive impairment: systematic review and meta-analysis.多奈哌齐用于癌症相关认知障碍:系统评价与荟萃分析
Clin Exp Med. 2025 Jun 10;25(1):196. doi: 10.1007/s10238-025-01708-w.
5
Incidence and predictors of immune checkpoint inhibitor treatment-related cognitive impairment in a racial and ethnic diverse population.种族和族裔多样化人群中免疫检查点抑制剂治疗相关认知障碍的发生率及预测因素。
Support Care Cancer. 2025 Jun 2;33(6):523. doi: 10.1007/s00520-025-09560-0.
应用修正后的应对晚期癌症模型,定性探讨肺癌幸存者持续身体影响、新治疗方法、不确定性和应对方法的体验。
J Cancer Surviv. 2024 Dec;18(6):1754-1770. doi: 10.1007/s11764-023-01417-x. Epub 2023 Jul 27.
4
Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.新诊断胶质母细胞瘤患者的神经认知障碍、神经行为症状、疲劳、睡眠障碍及抑郁症状
Neurooncol Pract. 2022 Sep 13;10(1):89-96. doi: 10.1093/nop/npac068. eCollection 2023 Feb.
5
Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor.接受原发性脑肿瘤放射治疗的成年人的神经认知表现。
Adv Radiat Oncol. 2022 Jul 16;7(6):101028. doi: 10.1016/j.adro.2022.101028. eCollection 2022 Nov-Dec.
6
The Cognitive Effects of Radiotherapy for Brain Metastases.脑转移瘤放疗的认知效应
Front Oncol. 2022 Jun 30;12:893264. doi: 10.3389/fonc.2022.893264. eCollection 2022.
7
Overall and sex-specific risk factors for subjective cognitive decline: findings from the 2015-2018 Behavioral Risk Factor Surveillance System Survey.总体和性别特异性主观认知衰退的危险因素:来自 2015-2018 年行为风险因素监测系统调查的结果。
Biol Sex Differ. 2022 Apr 12;13(1):16. doi: 10.1186/s13293-022-00425-3.
8
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.癌症临床试验中接受免疫治疗、靶向治疗或化疗的患者发生严重不良事件的风险的性别差异。
J Clin Oncol. 2022 May 1;40(13):1474-1486. doi: 10.1200/JCO.21.02377. Epub 2022 Feb 4.
9
The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis.立体定向或全脑放疗对脑转移成人患者神经认知功能的影响:系统评价和荟萃分析。
Oncol Res Treat. 2021;44(11):622-636. doi: 10.1159/000518848. Epub 2021 Sep 3.
10
Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.癌症幸存者的自我认知认知功能与生活质量:来自PROFILES注册研究的结果。
J Cancer Surviv. 2022 Apr;16(2):303-313. doi: 10.1007/s11764-021-01023-9. Epub 2021 Mar 17.